Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absence, accredited, ADC, adenocarcinoma, ADR, affirmed, aforementioned, aim, alcoholic, AML, anaplastic, Ann, Anokion, antidilutive, aprpoved, Ascend, atezolizumab, atrioventricular, banc, BCBSA, BCBSM, begun, bereavement, Black, Blue, bolstered, Boudry, Bravo, Breyanzi, Bristol, broader, BSC, carboplatin, cardiomyopathy, career, carefully, causation, certified, chemoradiation, chemoradiotherapy, child, Cigna, cisplatin, clause, clear, CMMoL, College, Color, commitee, commuter, compel, conspiracy, Cooperation, copay, corticosteroid, count, creation, cultivating, curative, cytarabine, cytokine, DAYBREAK, dental, deplete, derica, deucravacitinib, discourage, discouraging, discretionary, distancing, DMC, doctrine, doubling, downturn, Dragonfly, drawn, dynamic, dynamically, economy, elder, Elizabeth, embody, empower, en, endoscopic, enlarged, epidermal, equated, exacerbate, exciting, expenditure, family, feasibility, feedback, filtration, forum, fullest, gastroesophageal, gender, Genitourinary, glomerular, HCSC, heard, HHS, home, HPI, hypertrophic, hypomethylating, iberdomide, ICE, idecabtagene, IDHENTIFY, immunodeficiency, inapplicable, incentivize, induction, ineligible, influx, inspire, instance, intervention, isocitrate, JAK, junction, Kaposi, KarMMa, knowledge, lab, Latino, leader, learn, learning, led, legislature, lentiviral, lessen, lessor, lever, Living, lt, Lupin, lymphoblastic, Malignant, mavacamten, metastic, methyltransferase, MGMT, MHLW, military, Mily, Minnesota, mirror, mosaic, multiforme, myelomonocytic, MyoKardia, Negro, neoplasm, NMPA, noninfringement, nurturing, obstructive, onset, onsite, Ontario, Onureg, opted, Organisation, organizational, ORR, outpatient, Overnight, Pan, pandemic, parent, parental, parity, PASI, paula, pausing, PBRG, pemetrexed, pet, pharmacy, phishing, pioneering, Pleural, POETYK, Powell, precision, prejudgment, preliminarily, pretreated, PRIDE, prolonged, Prospanica, published, pulmonary, Quebec, recharge, recommenced, reconsider, recovered, recruiting, relieve, remission, remote, renegotiate, renegotiated, representation, residual, restarted, resumed, resumption, retiree, reverted, reward, rice, RMS, RNA, ruxolitinib, sarcoma, scarcity, Schwab, score, Septal, shape, shelter, Shield, sick, signature, Singapore, slowdown, sNDA, SOFR, solvency, soul, sPGA, spleen, splenomegaly, static, statue, steering, stimulating, stretch, stringent, strive, subgroup, sudden, surrogate, survey, switch, switching, Symposium, tangible, Tecentriq, tenure, thereunder, thriving, thrombocythaemia, Tolerance, training, transient, translocation, travel, traveling, TriPhase, True, tuition, Twelfth, UC, UHS, unblinded, undertook, unemployment, unified, unsatisfactory, unused, unyielding, USD, vacancy, vacation, vaccine, validly, valuable, vector, venue, vicleucel, vision, volunteer, warehousing, wider, withdrew, workday, workplace, worse, writing, xii, xiii, xiv, Zeposia, zone
Removed:
acceptance, accessing, adnectin, age, agonist, analgesic, ASEAN, asymptomatic, autoimmunity, bad, Belgium, bleeding, build, buyer, cabiralizumab, Cardioxyl, Connecticut, constitute, continuously, CytomX, depreciated, dMMR, dual, Duchenne, Dystrophy, Elicker, enactment, expecting, expressly, false, favor, financed, fragment, graduate, Gulf, IFM, India, infused, innate, intermediate, Investor, iPierian, John, lymph, minimally, minimize, modulate, Muscular, nominated, Palsy, passed, Perfalgan, postgraduate, powder, Prime, Probody, profession, prospectively, rated, realign, Redwood, revoked, Secretary, Silver, simplify, step, STING, stroke, subcutaneously, substitution, summarize, Supranuclear, symptomatic, transitional, undergone, uniquely, ViiV, vitamin, VTE, Wallingford
Filing tables
Filing exhibits
- 10-K Annual report
- 4 Description of Bristol-myers Squibb Companys Securities
- 10 Extension Notice for Revolving Credit Facility Dated September 29, 2011
- 10 Extension Notice for Revolving Credit Facility Agreement Dated July 30, 2012
- 10 Amendment to Revolving Credit Facility Dated September 29, 2011
- 10 Amendment to Revolving Credit Facility Dated July 30, 2012
- 10 Psu Award Agreement Under the 2012 Stock Award and Incentive Plan
- 10 Rsu Agreement with 5-YEAR Vesting Under the 2012 Stock Award and Incentive Plan
- 10 Rsu Agreement with 4-YEAR Vesting Under the 2012 Stock Award and Incentive Plan
- 10 Rsu Agreement with 2-YEAR Cliff Vesting Under the 2012 Stock Award and Incentive
- 10 Rsu Agreement with 1-YEAR Cliff Vesting Under the 2012 Stock Award and Incentive
- 10 Msu Agreement Under the 2012 Stock Award and Incentive Plan
- 10 BMS Benefit Equalization Plan - Retirement Income Plan
- 10 BMS Benefit Equalization Plan - Savings and Investment Program
- 10 Senior Executive Severance Plan
- 21 Exhibit 21
- 23 Exhibit 23
- 31 Exhibit 31.A
- 31 Exhibit 31.B
- 32 Exhibit 32.A
- 32 Exhibit 32.B
- Download Excel data file
- View Excel data file
Related press release
Associated BMY transcripts
BMY similar filings
Filing view
External links
EXHIBIT 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333‐236272 and 333-227304 on Form S‐3, No. 333‐238533 and 333-229464 on Form S‐4 and Nos. 333‐47403, 33‐52691, 333‐02873, 333‐65424, 333‐182405, 333-235254, and 333-237055 on Form S-8 of our reports dated February 9, 2021, relating to the consolidated financial statements of Bristol-Myers Squibb Company and subsidiaries and the effectiveness of Bristol-Myers Squibb Company and subsidiaries' internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.
/s/ DELOITTE & TOUCHE LLP
Parsippany, New Jersey
February 9, 2021
E-23-1